Product image of Lais Ragweed M (Ambrosia Artemisiifolia (302)) supplied by GNH India

Lais Ragweed M

Active Ingredient:
Ambrosia Artemisiifolia (302)
Origin:
EU

Lais Ragweed M (Ambrosia Artemisiifolia (302))

Ambrosia artemisiifolia, the active ingredient in Lais Ragweed M, is an allergen extract presented as an oromucosal preparation for sublingual use. It is used to treat allergic rhinitis caused by ragweed (Ambrosia artemisiifolia) exposure in patients with documented sensitivity.

GNH India supplies Lais Ragweed M as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Lofarma Spa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lais Ragweed M is an allergen extract used in allergy immunotherapy for ragweed‑related conditions.

  • Allergic rhinitis: reduces nasal congestion, sneezing and itching caused by ragweed exposure.
  • Seasonal allergic rhinitis: improves tolerance to ragweed pollen during peak seasons.
  • Ragweed‑induced allergic rhinoconjunctivitis: alleviates both nasal and ocular symptoms associated with ragweed allergy.

How It Works

  • Ambrosia artemisiifolia extract works by gradually exposing the immune system to controlled amounts of ragweed allergen via the oromucosal route, promoting the development of allergen‑specific regulatory T cells and shifting the immune response from a Th2‑dominant, IgE‑mediated pattern toward a more tolerant, IgG‑dominant profile, thereby reducing hypersensitivity reactions.

Side Effects

Lais Ragweed M may cause local and systemic reactions, most of which are mild and transient.

Common Side Effects

  • Oral itching or tingling: mild irritation in the mouth.
  • Throat irritation: sensation of soreness or scratchiness.
  • Local swelling: mild edema of the lips or tongue.
  • Nausea: occasional upset stomach.
  • Headache: mild to moderate intensity.
  • Mild cough: brief irritation of the airway.

Serious or Rare Side Effects

  • Anaphylaxis: severe, potentially life‑threatening allergic reaction.
  • Severe swelling of the throat or tongue: may compromise breathing.
  • Respiratory distress: difficulty breathing or wheezing.
  • Systemic allergic reaction: widespread hives or rash.
  • Angioedema: rapid swelling of face, lips, or eyes.
  • Cardiovascular collapse: rare drop in blood pressure.

Precautions & Warnings

Before initiating therapy with Lais Ragweed M, consider the following precautions.

  • Medical evaluation: confirm ragweed allergy through appropriate testing.
  • Existing severe asthma: assess risk as immunotherapy may exacerbate symptoms.
  • Recent anaphylaxis: avoid use until fully recovered and cleared by a physician.
  • Concomitant beta‑blocker therapy: monitor closely due to potential interference with emergency treatment of reactions.
  • Pregnancy and breastfeeding: use only if clearly needed and prescribed by a healthcare professional.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct light.

Avoid Interactions

Lais Ragweed M may interact with other medications or therapies.

Major Interactions (Avoid)

  • Concurrent allergen immunotherapy products: may increase risk of systemic reactions.
  • Beta‑blockers: can mask symptoms of anaphylaxis and interfere with emergency treatment.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: may enhance risk of angioedema.
  • NSAIDs: can potentiate allergic responses in sensitive individuals.
  • Immunosuppressants: may reduce efficacy of immunotherapy.
  • Antihistamines: may blunt clinical assessment of reactions.
  • Live vaccines: schedule administration apart from immunotherapy sessions.

Frequently Asked Questions

Lais Ragweed M is an allergen extract used in allergy immunotherapy to treat allergic rhinitis caused by exposure to ragweed (Ambrosia artemisiifolia). It helps the immune system become tolerant to ragweed pollen, reducing nasal and ocular symptoms during the allergy season.

The Ambrosia artemisiifolia extract in Lais Ragweed M introduces small, controlled amounts of ragweed allergen to the immune system via the oromucosal route. This exposure promotes regulatory immune pathways, shifting the response from IgE‑mediated allergy toward a more tolerant IgG‑dominant profile, thereby decreasing hypersensitivity.

The dosing regimen for Lais Ragweed M is individualized. A qualified healthcare professional determines the appropriate dose and schedule based on the patient’s allergy severity, age, and clinical response.

Safety of Lais Ragweed M in pregnancy or while breastfeeding has not been fully established. It should be used only if the potential benefit justifies the potential risk and under direct medical supervision.

To order Lais Ragweed M, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Lais Ragweed M is an oromucosal (sublingual) formulation, offering a non‑injectable alternative to traditional subcutaneous ragweed immunotherapy. It provides convenient self‑administration at home, which may improve adherence, while maintaining comparable efficacy in inducing tolerance.

Lais Ragweed M should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability.

The product is administered orally via the oromucosal route. The patient places the prescribed dose under the tongue and holds it for the recommended time before swallowing, following the prescriber’s instructions.

The most serious risks include systemic allergic reactions such as anaphylaxis, severe throat or tongue swelling, and respiratory distress. Patients should be educated to recognize early signs and seek immediate medical attention if they occur.

Lais Ragweed M is contraindicated in individuals with a history of severe anaphylactic reaction to ragweed allergen, uncontrolled asthma, or those receiving beta‑blocker therapy without medical supervision. It should also be avoided in patients with known hypersensitivity to any component of the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.